First-in-Human Study of VB0004 in Healthy Subjects and to Patients With Mild to Moderate Hypertension With Low Cardiovascular Risk
NCT04925050
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
88
Enrollment
OTHER
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
VB0004
OTHER:
Matching Placebo for VB0004
Sponsor
Syneos Health